Search research articles
Contact Us
Filters
Showing results (71-80 of 113) with videos related to
Page
of 12
Sort By:
Cell Reports
|
September 15, 2021
Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment
Hridesh Banerjee, Hector Nieves-Rosado, Aditi Kulkarni, et al.
Head & Neck
|
July 31, 2024
Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients
Dan P Zandberg, Serafettin Zenkin, Murat Ak, et al.
Journal for Immunotherapy of Cancer
|
March 13, 2023
Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors
Konstantinos Lontos, Yiyang Wang, Supriya K Joshi, et al.
Cell Reports
|
April 4, 2019
Lymphocyte Activation Gene-3 Maintains Mitochondrial and Metabolic Quiescence in Naive CD4<sup>+</sup> T Cells
Dana M Previte, Christina P Martins, Erin C O'Connor, et al.
Nature Immunology
|
April 12, 2016
Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation
Kristen N Pollizzi, Im-Hong Sun, Chirag H Patel, et al.
Nature Immunology
|
January 5, 2021
Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
Nicole E Scharping, Dayana B Rivadeneira, Ashley V Menk, et al.
Nature
|
August 6, 2013
Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis
Greg M Delgoffe, Seng-Ryong Woo, Meghan E Turnis, et al.
Oral Oncology
|
March 24, 2023
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck
Nicole N Scheff, Marci L Nilsen, Jinhong Li, et al.
The Journal of Experimental Medicine
|
August 8, 2023
An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment
Kristin DePeaux, Dayana B Rivadeneira, Konstantinos Lontos, et al.
Nature Immunology
|
February 7, 2012
The composition and signaling of the IL-35 receptor are unconventional
Lauren W Collison, Greg M Delgoffe, Clifford S Guy, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 113) with videos related to
Sort By:
Page
of 12
Cell Reports
|
September 15, 2021
Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment
Hridesh Banerjee, Hector Nieves-Rosado, Aditi Kulkarni, et al.
Head & Neck
|
July 31, 2024
Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients
Dan P Zandberg, Serafettin Zenkin, Murat Ak, et al.
Journal for Immunotherapy of Cancer
|
March 13, 2023
Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors
Konstantinos Lontos, Yiyang Wang, Supriya K Joshi, et al.
Cell Reports
|
April 4, 2019
Lymphocyte Activation Gene-3 Maintains Mitochondrial and Metabolic Quiescence in Naive CD4<sup>+</sup> T Cells
Dana M Previte, Christina P Martins, Erin C O'Connor, et al.
Nature Immunology
|
April 12, 2016
Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation
Kristen N Pollizzi, Im-Hong Sun, Chirag H Patel, et al.
Nature Immunology
|
January 5, 2021
Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
Nicole E Scharping, Dayana B Rivadeneira, Ashley V Menk, et al.
Nature
|
August 6, 2013
Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis
Greg M Delgoffe, Seng-Ryong Woo, Meghan E Turnis, et al.
Oral Oncology
|
March 24, 2023
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck
Nicole N Scheff, Marci L Nilsen, Jinhong Li, et al.
The Journal of Experimental Medicine
|
August 8, 2023
An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment
Kristin DePeaux, Dayana B Rivadeneira, Konstantinos Lontos, et al.
Nature Immunology
|
February 7, 2012
The composition and signaling of the IL-35 receptor are unconventional
Lauren W Collison, Greg M Delgoffe, Clifford S Guy, et al.
Page
of 12